Streetbeat News

Stock Prices

BMY

Bristol-Myers Squibb's shares rose following FDA approval of COBENFY for schizophrenia treatment.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 11:50 am

COIN

Vice President Kamala Harris is signaling a more pragmatic approach to cryptocurrency, diverging from the Biden administration's strict regulatory stance. This shift is seen as a potential 'crypto reset' by some Democrats, while others remain cautious. Harris's balanced stance aims to encourage digital asset growth while ensuring consumer protection, resonating with some in the crypto sector. The industry, including Coinbase's advocacy group, is closely monitoring her position.

Portfolio Pulse from Murtuza Merchant

September 27, 2024 | 11:47 am

AHH

CMCT

LRHC

The article highlights three oversold real estate stocks with potential for short-term gains: Armada Hoffler Properties (AHH), La Rosa Holdings (LRHC), and Creative Media & Community Trust Corp (CMCT). These stocks have low RSI values, indicating they may be undervalued.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 11:17 am

LYRA

Lyra Therapeutics will present results from its Phase 3 ENLIGHTEN 1 study for LYR-210 and additional results from the Phase 2 BEACON study for LYR-220 at the AAO-HNS Annual Meeting.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 11:08 am

BMY

DUO

ESTA

ONCO

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares surged 28.3% in pre-market trading after receiving FDA approval for Motiva Implants. Other notable pre-market movers include Fangdd Network Group Ltd. (NASDAQ:DUO), Onconetix, Inc. (NASDAQ:ONCO), and Bristol-Myers Squibb Company (NYSE:BMY), which saw significant gains due to various positive developments.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 10:46 am

BB

BMY

COST

QQQ

SPY

Wall Street is in a wait-and-watch mode ahead of key inflation data, with index futures indicating a modestly lower opening. The SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) showed slight movements in premarket trading. BlackBerry (BB) and Costco (COST) saw declines following earnings announcements, while Bristol Myers Squibb (BMY) rose after FDA approval of a new drug. Analysts predict increased volatility, providing potential entry points into a long-term bull market.

Portfolio Pulse from Shanthi Rexaline

September 27, 2024 | 10:39 am

PLTR

Peter Thiel has sold over $1 billion worth of Palantir Technologies Inc. stock in 2024, with recent sales of $600 million. Palantir's stock has more than doubled this year and was recently added to the S&P 500. Thiel's sales come amid his controversial public statements.

Portfolio Pulse from Kaustubh Bagalkote

September 27, 2024 | 10:35 am

ADRT

Ault Disruptive Technologies Corporation announced it will redeem its public shares and will not proceed with an initial business combination.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 10:33 am

HYZN

Hyzon Motors has regained compliance with Nasdaq listing standards after curing a bid price deficiency. This development ensures the company's continued listing on the Nasdaq exchange.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 10:32 am

CING

Cingulate has filed for the resale of up to 1.5 million shares by a selling stockholder, as per the SEC filing. This move could impact the stock's supply and demand dynamics.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 10:27 am